These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7473057

  • 1. [Synthesis and antiplatelet activity of 2-amino-4,5-diphenylthiazole derivatives].
    Inoue H, Ikesue K, Taniguchi Y.
    Yakugaku Zasshi; 1995 Aug; 115(8):603-10. PubMed ID: 7473057
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and platelet aggregation inhibitory activity of diphenylazole derivatives. I. Thiazole and imidazole derivatives.
    Seko N, Yoshino K, Yokota K, Tsukamoto G.
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):651-7. PubMed ID: 2070443
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives.
    Ferrarini PL, Badawneh M, Franconi F, Manera C, Miceli M, Mori C, Saccomanni G.
    Farmaco; 2001 Apr; 56(4):311-8. PubMed ID: 11421260
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet agents based on cyclooxygenase inhibition without ulcerogenesis. Evaluation and synthesis of 4,5-bis(4-methoxyphenyl)-2-substituted-thiazoles.
    Tanaka A, Sakai H, Motoyama Y, Ishikawa T, Takasugi H.
    J Med Chem; 1994 Apr 15; 37(8):1189-99. PubMed ID: 8164261
    [Abstract] [Full Text] [Related]

  • 6. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J, Muramatsu M, Hosoda K, Otomo S, Aihara H.
    Nihon Yakurigaku Zasshi; 1984 May 15; 83(5):395-400. PubMed ID: 6432657
    [Abstract] [Full Text] [Related]

  • 7. Effects of chroman derivatives on platelet aggregation induced by some aggregating agents in rabbits.
    Aida Y, Kasama T, Fukaya H, Takeuchi N, Sugiyama K, Tobinaga S.
    Clin Exp Pharmacol Physiol; 1998 Nov 15; 25(11):939-44. PubMed ID: 9807668
    [Abstract] [Full Text] [Related]

  • 8. Gamma-pyrone compounds. II: Synthesis and antiplatelet effects of tetraoxygenated xanthones.
    Lin CN, Liou SS, Ko FN, Teng CM.
    J Pharm Sci; 1992 Nov 15; 81(11):1109-12. PubMed ID: 1447715
    [Abstract] [Full Text] [Related]

  • 9. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K, Someya K, Tachiiri T, Mitsuoka Y, Nakamura K, Imai S, Ino T, Ohkubo H.
    Arzneimittelforschung; 1992 Jan 15; 42(1):32-9. PubMed ID: 1586377
    [Abstract] [Full Text] [Related]

  • 10. 2-Amino-Benzo[d]isothiazol-3-one derivatives: synthesis and assessment of their antiplatelet/spasmolytic effects.
    Vicini P, Amoretti L, Ballabeni V, Tognolini M, Barocelli E.
    Bioorg Med Chem; 2000 Sep 15; 8(9):2355-8. PubMed ID: 11026548
    [Abstract] [Full Text] [Related]

  • 11. N-substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity.
    Mirfazli SS, Kobarfard F, Firoozpour L, Asadipour A, Esfahanizadeh M, Tabib K, Shafiee A, Foroumadi A.
    Daru; 2014 Sep 20; 22(1):65. PubMed ID: 25238875
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH, Hsieh HK, Liu CT, Lin HC, Teng CM, Lin CN.
    J Pharm Pharmacol; 2004 Oct 20; 56(10):1333-7. PubMed ID: 15482650
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and preclinical pharmacology of KC-764, a novel antiplatelet agent].
    Yoshioka M, Soga T, Mase K, Yasunaga K.
    Nihon Rinsho; 1992 Feb 20; 50(2):379-84. PubMed ID: 1613994
    [Abstract] [Full Text] [Related]

  • 14. Effect of KBT-3022, a new diphenylthiazole derivative, on platelet functions.
    Yokota K, Yamamoto N, Morimoto Y, Yamashita A, Oda M.
    J Pharm Pharmacol; 1995 Sep 20; 47(9):768-74. PubMed ID: 8583391
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM, Jin HS, Sun LP, Piao HR, Quan ZS.
    Bioorg Med Chem Lett; 2005 Nov 15; 15(22):5027-9. PubMed ID: 16169724
    [Abstract] [Full Text] [Related]

  • 16. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC, Kummerle AE, Lugnier C, Fraga CA, Barreiro EJ, Miranda AL.
    Eur J Pharmacol; 2010 Jul 25; 638(1-3):5-12. PubMed ID: 20412790
    [Abstract] [Full Text] [Related]

  • 17. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
    da Silveira IA, Paulo LG, de Miranda AL, Rocha SO, Freitas AC, Barreiro EJ.
    J Pharm Pharmacol; 1993 Jul 25; 45(7):646-9. PubMed ID: 8105062
    [Abstract] [Full Text] [Related]

  • 18. Antiplatelet activity of some prenylflavonoids.
    Lin CN, Shieh WL, Ko FN, Teng CM.
    Biochem Pharmacol; 1993 Jan 26; 45(2):509-12. PubMed ID: 8435100
    [Abstract] [Full Text] [Related]

  • 19. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD, Stathopoulou EM, Papamichael ND, Englezopoulos CV, Rousouli KI, Trypou P, Moussis V, Tellis CC, Katsouras CS, Tsikaris V, Tselepis AD, Michalis LK.
    Platelets; 2011 Jan 26; 22(5):361-70. PubMed ID: 21158497
    [Abstract] [Full Text] [Related]

  • 20. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
    Konno S, Kokubo T, Amano M, Yoshida N, Sagi M, Yamanaka H.
    Yakugaku Zasshi; 1992 Oct 26; 112(10):729-41. PubMed ID: 1469603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.